No abstract available
MeSH terms
-
Antifibrinolytic Agents / adverse effects*
-
Cyclohexanecarboxylic Acids / adverse effects*
-
Female
-
Humans
-
Middle Aged
-
Pulmonary Embolism / chemically induced*
-
Pulmonary Embolism / drug therapy
-
Tranexamic Acid / adverse effects*
-
Urokinase-Type Plasminogen Activator / therapeutic use
Substances
-
Antifibrinolytic Agents
-
Cyclohexanecarboxylic Acids
-
Tranexamic Acid
-
Urokinase-Type Plasminogen Activator